| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | TNFSF13B | Synonyms | BAFF, BLYS, CD257, DTL, TALL-1, TALL1, THANK, TNFSF20, TNLG7A, ZTNF4 | Type of gene | protein-coding |
| Chromosome | 13 | Map location | 13q33.3 | dbXrefs | |
| Description | TNF superfamily member 13b | ||||
| GTO ID | GTC3771 |
| Trial ID | NCT06279923 |
| Disease | Systemic Lupus Erythematosus | Immune Nephritis | Systemic Sclerosis | Dermatomyositis | Neuromyelitis Optica |
| Altered gene | CD19|TNFSF13B |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BAFF/CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical Study of Targeting CD19-BAFF CAR-T Cells in the Treatment of Autoimmune Diseases |
| Year | 2024 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | TXB2023023 |
| Cohort 1 | |||||||
|
|||||||